Interference Requirements of Type III CRISPR-Cas Systems from Thermus thermophilus.


Journal

Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 02 09 2023
revised: 12 01 2024
accepted: 13 01 2024
medline: 18 3 2024
pubmed: 25 1 2024
entrez: 24 1 2024
Statut: ppublish

Résumé

Among the diverse prokaryotic adaptive immunity mechanisms, the Type III CRISPR-Cas systems are the most complex. The multisubunit Type III effectors recognize RNA targets complementary to CRISPR RNAs (crRNAs). Target recognition causes synthesis of cyclic oligoadenylates that activate downstream auxiliary effectors, which affect cell physiology in complex and poorly understood ways. Here, we studied the ability of III-A and III-B CRISPR-Cas subtypes from Thermus thermophilus to interfere with plasmid transformation. We find that for both systems, requirements for crRNA-target complementarity sufficient for interference depend on the target transcript abundance, with more abundant targets requiring shorter complementarity segments. This result and thermodynamic calculations indicate that Type III effectors bind their targets in a simple bimolecular reaction with more extensive crRNA-target base pairing compensating for lower target abundance. Since the targeted RNA used in our work is non-essential for either the host or the plasmid, the results also establish that a certain number of target-bound effector complexes must be present in the cell to interfere with plasmid establishment. For the more active III-A system, we determine the minimal length of RNA-duplex sufficient for interference and show that the position of this minimal duplex can vary within the effector. Finally, we show that the III-A immunity is dependent on the HD nuclease domain of the Cas10 subunit. Since this domain is absent from the III-B system the result implies that the T. thermophilus III-B system must elicit a more efficient cyclic oligoadenylate-dependent response to provide the immunity.

Identifiants

pubmed: 38266982
pii: S0022-2836(24)00014-7
doi: 10.1016/j.jmb.2024.168448
pii:
doi:

Substances chimiques

RNA, Guide, CRISPR-Cas Systems 0
RNA 63231-63-0
CRISPR-Associated Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

168448

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Karyna Karneyeva (K)

Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.

Matvey Kolesnik (M)

Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.

Alexei Livenskyi (A)

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119992, Russia.

Viktor Zgoda (V)

Institute of Biomedical Chemistry, Moscow 119435, Russia.

Vasiliy Zubarev (V)

Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.

Anna Trofimova (A)

Laboratory of Molecular Genetics of Microorganisms, Institute of Gene Biology, Russian Academy of Sciences, Moscow 119334, Russia.

Daria Artamonova (D)

Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.

Yaroslav Ispolatov (Y)

Departamento de Física, Center for Interdisciplinary Research in Astrophysics and Space Science, Universidad de Santiago de Chile, Victor Jara 3493, Santiago, Chile.

Konstantin Severinov (K)

Waksman Institute, Rutgers, The State University of New Jersey, NJ 08854, USA. Electronic address: severik@waksman.rutgers.edu.

Articles similaires

Prader-Willi Syndrome Humans Angelman Syndrome CRISPR-Cas Systems Human Embryonic Stem Cells
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition
Genome, Bacterial Virulence Phylogeny Genomics Plant Diseases
DNA Methylation Humans DNA Animals Machine Learning

Classifications MeSH